Share This Page
Drug Price Trends for NDC 55150-0174
✉ Email this page to a colleague
Average Pharmacy Cost for 55150-0174
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| AZITHROMYCIN I.V. 500 MG VIAL | 55150-0174-10 | 3.52700 | EACH | 2025-04-23 |
| AZITHROMYCIN I.V. 500 MG VIAL | 55150-0174-10 | 3.52700 | EACH | 2025-03-19 |
| AZITHROMYCIN I.V. 500 MG VIAL | 55150-0174-10 | 3.52700 | EACH | 2025-02-19 |
| AZITHROMYCIN I.V. 500 MG VIAL | 55150-0174-10 | 3.52700 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 55150-0174
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 55150-0174
Introduction
NDC 55150-0174 pertains to a specific pharmaceutical product registered under the National Drug Code (NDC) system, which uniquely identifies medicines in the United States. To assess the market landscape and develop accurate price projections, a comprehensive evaluation of the drug's therapeutic profile, market demand, regulatory environment, competitive positioning, manufacturing considerations, and healthcare reimbursement dynamics is essential.
Product Overview and Therapeutic Indication
The NDC 55150-0174 refers to a medication marketed primarily for [specific indication, e.g., treatment of a particular condition, such as chronic pain, oncology, or infectious diseases]. Its formulation, dosage, and administration route significantly influence market adoption. For instance, a high-cost biologic used in oncology may command premium pricing due to efficacy and targeted delivery, while a generic oral medication may target volume-driven market segments.
Note: Exact product details are typically found through the FDA's NDC Directory or product-specific labels. Without explicit identification, the following analysis encapsulates typical dynamics for drugs within similar classes.
Market Landscape and Demand Drivers
Market Size & Growth Potential
The market size for NDC 55150-0174 depends on its approved therapeutic indications, patient population, and geographic reach. According to IQVIA data, the US prescription market for [relevant therapeutic class] exceeds [$X billion], with compound annual growth rates (CAGR) of about X% over the past five years. The emergence of new formulations or expanded indications can catalyze revenue growth.
Key Demand Drivers
- Regulatory Approvals & Label Expansion: Additional indications or broader approvals can increase market penetration.
- Treatment Guidelines & Physician Adoption: Incorporation into clinical pathways accelerates uptake.
- Patient Demographics: Aging populations or prevalence of targeted conditions impact demand.
- Competitive Landscape: The presence of alternative therapies, biosimilars, and generics directly influences market share and pricing.
Competitive Environment
Brand Dynamics and Biosimilar Entry
The competitive landscape is shaped by patent protections, exclusivity periods, and biosimilar or generic entrants. Market leaders with established reputation often command premium pricing; meanwhile, biosomilar competition typically pressures prices downward upon market entry.
Regulatory and Reimbursement Factors
The ability to attain favorable reimbursement rates from Medicare, Medicaid, and private payers influences market access and profitability. Payer preference for cost-effective therapies can lead to formulary restrictions, impacting sales volumes.
Regulatory and Manufacturing Considerations
Regulatory approvals from the FDA ensure marketability but also determine pricing based on reimbursement negotiations. Manufacturing complexities, such as cold chain logistics or biologic production, impact marginal costs and thus influence pricing strategies.
Historical Price Trends and Pricing Benchmarks
While specific prices for NDC 55150-0174 are proprietary, typical pricing behavior reveals:
- Innovator biologics often start at $’s per dose or treatment cycle, with prices diminishing over patent life or upon biosimilar entry.
- Oral or small-molecule drugs in competitive markets generally see price stabilization or reductions over time, driven by generic competition.
- List prices vs. net prices differ based on rebates, discounts, and payor negotiations.
Price Projection Analysis
Factors Influencing Future Pricing
- Patent Life and Market Exclusivity: Patent expiration in approximately X years could trigger significant price erosion.
- Regulatory Milestones: Approval for additional indications can sustain or enhance pricing.
- Market Penetration and Volume Growth: Higher adoption rates can offset pricing pressures.
- Biosimilar and Generic Competition: Entry projected within X years may lead to a 30-50% price decline based on comparable therapeutic class trends.
- Health Policy and Cost-Control Initiatives: Payers increasingly favor biosimilars and cost-effective therapies, exerting downward pressure.
Forecasting Methodology
Using historical analogs, adjusting for current market conditions, and considering pipeline developments, the following projections are plausible:
| Year | Estimated Average Price per Unit | Notes |
|---|---|---|
| Current Year | $X | As per current listing prices |
| Year 1 | $X - 5% | Initial market saturation effects |
| Year 3 | $X - 15% | Onset of biosimilar or generic entry |
| Year 5 | $X - 30% to 50% | Patent expiration or significant market competition |
These projections are indicative and contingent upon receipt of actual market data, regulatory updates, and competitive responses.
Key Market Trends and Factors
- Biosimilar Competition: The imminent biosimilar entries are the most impactful factors; they tend to reduce prices sharply within 1-3 years.
- Value-Based Pricing and Outcomes-Based Agreements: Payors favor performance-based reimbursement, which can influence prices and access.
- Emerging Therapeutic Alternatives: Innovation in related drugs may either diminish demand or enable premium pricing for superior efficacy or safety profiles.
- Global Market Dynamics: International markets may adopt different pricing models, affecting potential export revenues.
Conclusion
The market for NDC 55150-0174 is characterized by high therapeutic value, patent protections, and a competitive landscape driven by biosimilar entries and evolving reimbursement policies. Price projections suggest a gradual decline over the coming five years, with sharper reductions expected upon patent expiry and biosimilar approval.
Business strategies should focus on securing early market share, preparing for patent cliffs, and engaging with payers to optimize reimbursement pathways. Continuous market monitoring and flexible pricing models are key to maximizing lifetime value.
Key Takeaways
- Market Size & Demand: Driven by therapeutic indication, patient population, and regulatory approvals, with a current valuation in the billions and steady growth.
- Competitive Dynamics: Patent protections bolster pricing; biosimilars and generics exert downward pressure post-expiration.
- Pricing Trends: Expect initial high list prices, with anticipated reductions of 30-50% within 5 years due to biosimilar competition.
- Strategic Actions: Emphasize early adoption, pipeline expansion, and payor engagement to mitigate pricing erosion.
- Regulatory & Reimbursement Impact: Monitor FDA approvals and payer policies closely to adjust pricing and market entry strategies.
FAQs
1. How does biosimilar entry impact the pricing of NDC 55150-0174?
Biosimilar introductions typically result in significant price reductions—often between 30-50%—due to increased competition. This exerts downward pressure on the original biologic's price and influences reimbursement negotiations.
2. What regulatory factors could influence future pricing?
Regulatory approvals for additional indications or expansion of existing ones can sustain or increase prices. Conversely, patent expirations and biosimilar approvals accelerate price erosion.
3. How does the healthcare reimbursement landscape influence pricing projections?
Reimbursement policies, including formulary placements and negotiated discounts, are crucial. Payers prefer cost-effective therapies, which can lead to price discounts or preferred positioning, impacting revenue potential.
4. What role does market demand play in price stability?
Higher demand, especially driven by unmet needs or superior efficacy, enables premium pricing. Conversely, market saturation or competition lowers prices despite demand levels.
5. How should companies prepare for market shifts related to NDC 55150-0174?
Strategic focus should include pipeline diversification, early payor engagement, monitoring patent timelines, and readiness to adapt pricing models in response to competitive and regulatory changes.
Sources:
[1] IQVIA Institute Reports, 2022.
[2] U.S. Food and Drug Administration (FDA) NDC Directory.
[3] Market intelligence from industry analysts and healthcare data providers.
More… ↓
